The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen, is scheduled to face tough questions Tuesday on Capitol Hill about the high costs of the company’s widely popular ...
Novo Nordisk skifter brandstrategiKort før regnskabet for første halvår skal offentliggøres, og mens Novo Nordisk stadig ikke har fundet en ny topchef, der kan afløse opsagte Lars Fruergaard Jørgensen ...
Novo Nordisk NVO recently underwent a major leadership transition, as Lars Fruergaard Jørgensen stepped down as CEO on Aug. 7, 2025, after leading the company since 2017. His tenure saw remarkable ...
On Tuesday, Novo Nordisk named Mike Doustdar as the company's new CEO. He'll begin his tenure on Aug. 7, just months after the unexpected removal of its previous CEO, Lars Fruergaard Jørgensen. While ...
Novo Nordisk said Friday that CEO Lars Fruergaard Jørgensen is stepping down as the Wegovy maker seeks to revive its ailing fortunes amid increasing competition. Stream Los Angeles News for free, 24/7 ...
Novo Nordisk said Tuesday it was tapping Maziar Mike Doustdar, its head of international operations, as its new CEO. Novo’s current CEO, Lars Fruergaard Jørgensen, announced he was stepping down in ...
Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk A/S (NYSE: NVO), Lars Fruergaard Jørgensen is on the outs. On May 16, Novo made the announcement that ...
This week, Novo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi SNY announced the proposed acquisition of Vigil Neuroscience, a ...
As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar Mike Doustdar, the company isn't making a point to rapidly add staffers. “We ...